BIASCA, Switzerland—In late March, Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, announced that its Swiss manufacturing company, Helsinn Advanced Synthesis SA, has won awards for the fourth year running in all categories at the 2018 CMO Leadership Awards. The awards, which recognize the leading contract manufacturing organizations, are based on customer feedback gathered by Industry Standard Research.
Helsinn won awards—in the overall and small pharma categories—for quality, reliability, capabilities, expertise, compatibility and service.
“It is a great honor for Helsinn to have been recognized for the fourth year running for the all-round quality of our manufacturing. Helsinn Advanced Synthesis is a cornerstone of Helsinn’s business and is also a highly-trusted partner for industry,” said Riccardo Braglia, Helsinn Group vice chairman and CEO. “Winning across all categories for another consecutive year is a great accomplishment, a testament to the quality and hard work of the staff.”
Added Waldo Mossi, Helsinn Advanced Synthesis’s general manager: “Our quality is our calling card, and the recognition of our peers is critical to our reputation. I would like to thank the outstanding team at Helsinn Advanced Synthesis for their reliably high-quality work and their relentless commitment.”